Enthesitis Related Arthritis (ERA)
Also known as: Enthesitis Related Arthritis / Enthesitis-related Arthritis / Juvenile chronic arthritis (disorder) / Arthritis, Juvenile / Juvenile arthritis / Juvenile idiopathic arthritis / Juvenile idiopathic arthritis (disorder) / Juvenile arthritis, unspecified
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09029 | Secukinumab | An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09029 | Secukinumab | Interleukin-17A | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00051 | Adalimumab | 3 | Active Not Recruiting | 1 |
| DB00051 | Adalimumab | 3 | Completed | 1 |
| DB11569 | Ixekizumab | 3 | Active Not Recruiting | 1 |
| DB09029 | Secukinumab | 3 | Active Not Recruiting | 1 |
| DB09029 | Secukinumab | 3 | Completed | 1 |